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Summary: August 29/October 24, 1984An enzymatic assay for the determination of the concentrations of
various ß-lactam antibiotics in serum, urine, and cerebrospinal fluid samples is described. Recently developed
ß-lactam derivatives are used äs competitive inhibitors of the breakdown of the labile coloured ß-lactam
compound PADAC®, which serves äs the Substrate for the various ß-lactamases. Under the conditions of
the assay, there is effectively no interference due to the matrix. Moreover, the assay is not influenced by
other antibiotics such äs aminoglycosides, macrolides, ansamycines, tetracyclines, fusidic acid or fosfomycin.
The C. V.s for within-run precision ranged from 3.7% to 4.4%, depending on the ß-lactam derivative. The
sensitivity of the assay is at least comparable with that of conveiitional procedures. Excellent correlations
were observed between the enzymatic and the nücrobiological procedures; correlation coefficients: r = 0.988
for 22 imipenem samples, r = 0.968 for 16 cefotaxime samples, and r = 0.989 for 16 piperacillin samples
routinely sent to our laboratofy.
Enzymatische Bestimmung von ß-Lactamantibiotika in Serum, Liquor und Urin
Zusammenfassung: In der vorliegenden Arbeit wird ein enzymatisches Verfahren zur Bestimmung der Konzen-
tration verschiedener ß-Lactamantibiotika in Serum, Urin und Liquorproben beschrieben. Dieses Verfahren
beruht auf der körhpetitiven Hemmung der Hydrolyse des chrpmogenen Cephalosporins PADAC®, das als
Substrat für die verschiedenen ß-Läctamaseii dient, durch die neueren ß-Lactamderivate. Unter den vorgege-
benen Bedingungen können Störungen,— bedingt durch die Matrix der Probe — weitestgehend ausgeschlossen
werden. Andere Antibiötika wie Aminoglykoside, Makrolide, Ansämycinderivate, Tetrazykline, Fusidinsäure
und Fosfomycin stören die Bestimmung nicht. Die Präzision in der Serie schwankte in Abhängigkeit des ß-
Lactamderivates zwischen 3,7 und 4,4%. Die Empfindlichkeit des vorgeschlagenen enzymatischen Verfahrens
ist durchaus mit derjenigen konventioneller Methoden vergleichbar. Der Vergleich des enzymatischen Verfah-
rens mit dem Bioassay (mikrobiologische Bestimmung) ergab eine ausgezeichnete Übereinstimmung: bei 22
Imipenem-Pfoben wurde ein Korrelationskoeffizieiat r = 0,988, bei 16 Cefotaxim-Proben r = 0,968 und bei
16 Piperacillin-Proben r = 0,989 erhalten.
J) Reportedi in part at the "Biochemische Analytik '84" in Mimich, April 1984(1).
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Introduction
At present concentrations of ß-lactam antibiotics are
determined either by an agar diffusion test or by high
Performance liquid chromatography (2). As these
methods are time-consuming and often require pre-
treatment of the samples, their routine use is re-
stricted to experienced laboratories. The new
methoxyiminocephalosporins are known to exhibit
high affmity for the chromosomally mediated ß-
lactamase from Enterobacter cloacae and can be con-
sidered competitive inhibitors. This suggested the
possible enzymatic determination of cefotaxime con-
centrations (3, 4): hydrolysis of the labile coloured
cephalosporin compound PADAC® was com-
petitively inhibited by cefotaxime, and the Inhibition
of enzyme activity was related to the cefotaxime con^
centration (4). In a previous study it was demon-
strated that most of the recently developed ß-lactam
compounds exhibit high affinity to ß-lactamases and
are fairly stable against breakdown by various
enzymes. It seemed reasonable to explore the use of
such an assay for the determination of a variety of
therapeutically relevant compounds (5). The en-
zymatic assay can be scheduled äs follows:
I. ß-lactam compound + ß-lactamase ^± [inactive
complex]
II. ß-lactamase (remaining) ^± hydrolysis of the sub-
strate PADAC® (decrease in absorbance at
575 nm)
It had already been reported in the literature that
PADAC® is well suited for this purpose, because
there is no nonspecific cleavage of this compound by
a biological matrix (3, 4). In the present work, such
an enzymatic assay for various ß-lactam compounds
is described and compared with conventional pro-
cedures.
Material and Methods
Samples
All samples (serum, bile) investigated in this study were
routinely sent to our laboratory and represented unselected
clinical material. Bile samples (2 ml aliquots) were collected in
tubes containing 0.4ml morpholine propane sulphonate
(MOPS) buffer (0.1 mol/1) thus maintaining a final pH between
7.0 and 7.5 in the bile samples (6). A pool serum was obtained
from 10 healthy donors. Cerebrospinal fluid was pooled from
20 samples sent to our laboratory which revealed no bacteria
when cultured. Urine samples were obtained from healthy
persons who had not received antibiotic treatment within the
previous 4 weeks. All samples were analysed either at once or
kept frozen for a maximum of 14 days at —70°C.
Enzymes
The TEM-1 enzyme (a broad-spectrum, plasmid-mediated ß-
lactamase) from E. coli K12 R6K was a commercially available
preparation from Boehringer Mannheim (FRG). The Entero-
bacter cloacae 2240 and the Citrobacter freundii 82 enzymes
were prepared äs described elsewhere without the second
Chromatographie Step (7); the enzyme from Proleus vulgaris
4917 was prepared analogously.
Equ ipment
A Zeiss PM 7 (Carl Zeiss, Oberkochen) s^ectrophotometer with
printer was used. A temperature of 25 °C was maintained during
all experiments. A triethanolamine buffer (0.05 mol/1) adjusted
to ph 7.5 was used throughout the experiments.
Microbioiogical procedures
For the microbiological determination of imipenem,
cefotaxime, and piperacillin concentrations, the following
strains were employed: Bacillus subtilis ATCC 6633 for im-
ipenem (obtained from MSD Sharp & Dohirie, Munich),
Escherichia coli 6311/65 for cefotaxime (obtained from Hoechst
A. G., Frankfurt), and Micrococcus luteus for piperacillin
(obtained from Deutsche Sammlung für Mikroorganismen,
strain no. 348, Göttingeii). In eäch case, the assay was carried
out according to the manufacturer's mstructions.
Reagents
The antibiotics used in this study were obtained from the
following sources:
ampicillin, cefuroxime, cefotaxime, HR810, HR221, and the
quinolone compound ofloxaciü from Hoechst A. G., Frankfurt
(FRG);
oxacillin, mezlocillin, and azlocillin from Bayer Leverkusen
(FRG);
piperacillin from Cyanamid Lederle, Wolfratshausen (FRG);
ticarcilliii, temocillin, and clavulanic acid from Beecham-WüL·
fing, Neuss (FRG);
ceftizoxime and fosfomycin from Boehringer Mannheim
(FRG);
cefmenoxime and rifainpicin (an ansamycine) from Täkeda-
Grünenthal, Stolberg (FRG);
ceftriaxone from Hoffmann La Röche, Basel (Switzerland);
ceftazidime from Cascan, Wiesbaden^ (FRG);
cefoxitin, imipenem (synonym: N-formimidoyl thienamycin),
and cilastin from MSD Sharp & Dohme, Munich (FRG);
lamoxactam from Eli Lilly, Gießen (FRG);
the monobactam aztreonam from Squibb-Heyden, Munich
(FRG);
gentamicin from E. Merck Darmstadt (FRG);
fusidic acid, erythromycin, and tetracycline from Sigma Cbern.,
Munich (FRG).
All other reagents of analytical grade were obtained from
E. Merck, Darmstadt (FRG). The chromogenic cepha-
losporin compound 7-(thienyl-2-acetamidp)-3-[2-(4-N,N-di-
methylamino phenylazo)-pyridinium methyl]-3-cephem-4-car-
boxylic acid (PADAC®) was kindly süpplied by Dr. Schindler,
Hoechst A. G., Frankfurt (FRG); its molar absorption coeffi-
cient at = 575 nm was reported to be 40 3 (m2/mol)
(4).
Results
«·>
Methodological studies
The , -values for the enzymes employed and the
chromogenic cephalosporin compound PADAC® are
shown in tablel. It is evident that the chromogenic
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Tab. l. Properties of the ß-lactamases used for enzymatic determination of ß-lactam antibiotic concentrations.
Enzyme from For determination of
E. coli K 12 R6K: TEM-1
Enterobacter cloacae 2240
Citrobacier freundii 82
Proteus vulgaris 4917
5.5 x 10-5
1.2 10-4
1.7 10-4
3.3 10-5
imipenems
penams (broad-spectrum penicillins)
cephems (cephalosporins)
clavulanic acid; oxacillin in the presence of ampicillin
mezlocillin
or
compound exhibits only a moderate affinity for the
enzymes. The Substrate concentration should not
exceed 5 10~5 mol/1, which corresponds to an
absorbance of 2.000, e. i. Substrate turnover should
not exceed a fraction of 0.10 of the total Substrate
concentration, in order to maintain zero-order
kinetics.
To rule out inferferences between the ß-lactamase
employed and the sample matrix we investigated
whether the sample matrix influences enzyme activity.
The activity of each enzyme decreased when the
amount of serum (or bile) exceeded a volume fraction
of 0.10 of the total assay volume (fig. 1). Similar
fmdings were obtained for individual samples äs well
äs for the pool serum. Urine and cerebrospinal fluid
did not influence enzyme activity (data not shown).
With due regard for these conditions, the assay can
be scheduled äs follows:
0.40 ml 0.05 mol/1 triethanolamine buffer containing
the Substrate PADAC® in a final concentration
of5 10"5 mol/1,
0.02 ml sample and
0.02 ml enzyme solution;
measure decrease in absorbance düring l or 2 niinutes
at 575nm(25°C).
0.150
0.05 0.10
Serum fraction
Fig. l. Increasing amounts of serum in the reaction mixture
cause a decrease of enzyme activity. Similar fmdings
were made for all enzymes. No discrepancies existed
between the pool serum and individual samples. Stan-
dard conditions; enzyme from Proteus vulgaris.
Enzyme catalytic concentration was adjusted to a
decrease of absorbance of A = 0.100/min. For the
analysis of cerebrospinal fluid it may be useful to
enhance the sensitivity of the assay; in these cases
0.05 ml sample volume can be used. Both ticarcillin
and ceftazidime are known to react slowly with the
Enterobacter cloacae and the Citrobacter freundii
enzyme, respectively. Therefore a preincubation
period of at least 2 minutes was maintained before
monitoring the decrease of absorbance.
With the above described conditions linear slope
functions were obtained for all antibiotics listed in
table 2; the data for imipenem are shown in figure 2.
For therapeutic use imipenem is used in combination
with cilastin — a dihydropeptidase inhibitor. Further
experiments revealed that cilastin did not interfere
with the enzymatic determination of imipenem. At
present, concentrations of some new ß-lactam com-
potinds (temocillin, cefoperazone, cefsulodin, the
compound HR 810, the oxacephem lamoxactam, and
Tab. 2. Sensitivity of the enzymatic assay for determination of
ß-lactam antibiotic concentrations in biological fluids.
ß-Lactam
compound
Imipenem
Cefuroxime
Cefotaxime
Cefmenoxime
Ceftriäxone
HR221
Ceftizöxime
Ceftazidime
Cefoxitin
Ampicillin
Mezlocillin
Azlocillin
Piperacillin
Ticarcillin
Oxacillin
Oxacillin
Clavulanic acid
Enzyme employed
TEM-1
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Citrobacter freundii
Enterobacter cloacae
Enterobacter cloacae
Enterobacter cloacae
Enterobacter cloacae
Enterobacter cloacae
Enterobacter cloacae
Proteus vulgaris
Proteus vulgaris
Sensitivity of
the assay
mg/1
0.6-10
0.04-0.9
0.03-0.7
0.05-1.2
0.04-0.8
0.3-7.5
1.5-40
2.0-50
1.5-40
2.0-50
10-250
4-90
3-60
0.03-0.7
0.01-0.3
2.0-50
0.5-10
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0.100
-0.5 0 0.5
I m i p e n e m [log mg / l ]
Fig. 2. Linearity of the enzymatic assay; analogous findings
were obtained for all other compounds.
O pool serum, urine, and O buffer;
Standard conditions;
enzyme from Enlerobacter cloacae.
t i m i n ]
Fig. 3. Incubation of various ß-lactam compounds with the
enzyme from Proteus vulgaris. Aliquots were taken at
various time intervals and the remaining enzyme activity
was determined with the chromogenic compound
PADAC®.
Ampicillin is rapidly broken down, whereas oxacillin is
stable for l hour. ClaVulanic acid inhibits the enzyme
progressively.
O 10 mg/1 ampicillin,
O 100 mg/1 ampicillin,
D 10 mg/1 oxacillin,
A l rag/1 clavulanic acid,
control assay; Standard conditions.
the monobactam aztreonam) cannot be determined
enzymatically either because they lack affmity for the
enzymes, or they show non-competitive Inhibition of
enzyme activity.
The assay remained unaffected by 100 mg/1
gentamicin, tetracycline, erythromycin, rifampicin,
fusidic acid, fosfomycin, and the quinolone com-
pound ofloxacin.
Combination of ß-lactam antibiotics
The enzymatic assay cannot be used for combinations
of 2 ß-lactam compounds, when both are stable to
hydrolysis by the enzyme employed, and both exhibit
high affmity for the enzyme. Ampicillin and
mezlocillin are used widely in combination with
oxacillin. In this case oxacillin levels can be easily
determined after pre-incubation with the enzyme
from Proteus vulgaris, äs ampicillin and mezlocillin
are rapidly inactivated (fig. 3). For this purpose the
assay has to be modified äs follows:
0.40 ml buffer containing the enzyme and
0.02 ml sample;
mix and incubate (25°C or 37°C) for approximately
30 minutes; add 0.02ml Substrate solution (9.5
10"4mol/l PADAC®) and measure decrease in
absorbance at 575 nm for l or 2 minutes.
As clavulanic acid exhibits time-dependent pro-
gressive Inhibition of enzyme activity after some min-
utes, this modified assay canript be used for the
determination of clavulanic acid in the presence of
ampicillin or amoxycillin (fig. 3).
Within-run and day to day precision
Within-run precision revealed C. V.s between 3.7 and
4.4% for all ß-lactam antibiotics. Day to day pre-
cision revealed a C. V. of 6.7% for cefotaxime.
Comparison of the enzymatic with the
microbiological procedure
A comparison of both pröcedures was performed for
piperacillin, cefotaxime, and imipenem. There were
good correlations between both procedufes for all
three compounds: for imipenem r was 0.988 (y =
0.968x - 0.07) for the 12 serum samples, and 0.845
(y = l.Olx + 0.91) for the 11 bile samples; överall
correlation resulted in r == 0.988 (y = 0.951x + 0.62)
(fig. 4a). For cefotaxime (16 serum samples) r was
0.968 (y = 0.78x + 1.19) (fig.4b) and for piperacillin
0.989 (y = 1.03x - 5.7) (datä for piperacillin not
shown). »
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Imipenem (enzymatic assay) [mg/U
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Fig. 4a. Comparison of the enzymatic with the microbiological Fig. 4b. Comparison of the enzymatic with the microbiological
procedure for imipenem (12 serum and 11 bile procedure for cefotaxime (l 6 serum samples);
samples). y = 0.796x + 1.18, r = 0.968, p < 0.001.
O serum, O bile;
y = 0.949x + 0.688, r « 0.988, p < 0.001.
Discussion
In view of the reported occurrence of side effects
from ß-lactam antibiotics, a rapid procedure for mon-
itoring these compounds is needed. Above all, such
an assay should be easy to perform and provide
results within a few hours.
Our findings clearly deinonstrate that the enzymatic
assay is äs sensitive äs the Standard procedures and
requires only a small sample volume, which may be
of advantage with respect to pediatric patients. The
wide spread use of ß-lactam antibiotics in combin-
ation with aminoglycosides or macrolides is often
associated with analytical problems; however, the
enzymatic assay does not interfere with antibiotics
other than ß-lactam compounds. The sensitivity of
the enzymatic assay deserves special attention for
the pharmacokinetic evaluation of new compounds
exhibiting high affinity fof one of the various
enzymes. Some compounds* such äs cefotaxime, are
subject to metabolism, but the de-acetyl derivative
does not affect the assay because of its lowered affin-
ity to the enzyme (3). This aspect deserves attention,
äs the de-acetyl derivative exhibits önly weak
antibacterial activity (3).
It can be seen that the assay is of limited value for
combinations of 2 ß-lactam antibiotics. In com-
binations of ampicillin or mezlocillin with pxacillin
however, oxacillin concentrations can be determined
with the Proteus vulgaris enzyme. This procedure is
somewhat easier to handle than the microbiological
procedure, which requires destruction of ampicillin
prior to the assay.
The interaction of clavulanic acid with the Proteus
vulgaris enzyme deserves further characterization. A
mechanism related to that reported for the
Escherichia coli TEM-1 enzyme may be assumed (9),
i. e. the first Step of the interaction of clavulanic acid
with the enzyme can be considered to be competitive,
followed by a progressive irreversible inactivation of
the enzyme.
The determination of imipenem by conventional pro-
cedures provides severe problems, because of the in-
stäbility of the drug during storage and change of
temperature. Thereföre, the enzymatic assay can be
employed with advantage, thereby overcoming the
slow nonspecific breakdown of this agent. This aspect
deserves attention in the analysis of bile samples,
because the imipenem is less stable at acidic or alka-
line pH (8), which explains the slight discrepancies
between the enzymatic and the microbiological pro-
cedures.
At the moment interest is focused on the assay of
imipenem, methoxy-imino cephalosporins, and
lamoxactam. Unfortunately, lamoxactam lacks either
binding or competitive Inhibition of the above ß-
lactamases. With the characterization of further
enzymes, assay procedures will become available for
those compounds that cannot be assayed at present.
J. Clin. Chem. Clin. Biochem. / VoL 23, 1985 / No. 3
156 Cullmann, Dick and Bdelmann: Enzymatic assay of ß-lactam antibiotics
References
1. Dick, W. & Cullmann, W. (1984) Fresenius Z. Anal. Chem.
317, 717-718.
2. Barza, M. & Lauermann, M. (1978) Clin. Pharmakokinetics
3, 202-215.
3. Seibert, G. & Biebach, A. (1981) J. Clin. Chem. Clin.
Biochem. /P, 279-282.
4. Schindler, P. & Huber, G. (1980) In: Enzyme Inhibitors
(Brodbeck, U., ed.) pp. 169-176. Verlag Chemie, Weinheim.
5. Cullmann, W. (1985) Chemotherapy (Basel), in press.
6. Norrbft S. R., Alestig, K., Björngard, B., Burman, L. A.,
Ferber, F., Huber, J. L., Jones, K. H., Kahan, F. M., Kahan,
J. S., Krppp, H., Meisinger, M. A. P. & Sundelof, J. G. (1983)
Antimicrob. Agents Chemother. 23, 300-^307.
7. Cullmann, W. & Dick, W. (1983) Zbl. Bakt. Hyg., 1. Abt.
Orig. A 254, 413-422.
8. Noitby, S. R., Björnegard, B., Ferber, F. & Jones, K. H.
(1983) J. Antimicrob. Chemotherapy (Suppl. D) /2,
109-124.
9. Charnäs, R. L., Fisher, J. & Knowles, J.R. (1978)
chemistry 17, 2185-2189.
Dr. Wolfgang Cullmann
Lehrstuhl für Med. Mikrobiologie
und Immunologie
der Ruhr-Universität Bochum
Postfach 10 21 48
D-4630 Bochum l
J. Clin. Chem. Clin. Biochem. / Vol. 23, 1985 / No. 3
